ロード中...
Allosteric modulation of group III metabotropic glutamate receptor 4: A potential approach to Parkinson's disease treatment
Parkinson's disease (PD) is a debilitating movement disorder that afflicts >1 million people in North America. Current treatments focused on dopamine-replacement strategies ultimately fail in most patients because of loss of efficacy and severe adverse effects that worsen as the disease prog...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
National Academy of Sciences
2003
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC263871/ https://ncbi.nlm.nih.gov/pubmed/14593202 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1835724100 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|